Substance use and the quality of patient-provider communication in HIV clinics
- PMID: 20703792
- PMCID: PMC3077450
- DOI: 10.1007/s10461-010-9779-8
Substance use and the quality of patient-provider communication in HIV clinics
Abstract
The objective of this study was to estimate the influence of substance use on the quality of patient-provider communication during HIV clinic encounters. Patients were surveyed about unhealthy alcohol and illicit drug use and rated provider communication quality. Audio-recorded encounters were coded for specific communication behaviors. Patients with vs. without unhealthy alcohol use rated the quality of their provider's communication lower; illicit drug user ratings were comparable to non-users. Visit length was shorter, with fewer activating/engaging and psychosocial counseling statements for those with vs. without unhealthy alcohol use. Providers and patients exhibited favorable communication behaviors in encounters with illicit drug users vs. non-users, demonstrating greater evidence of patient-provider engagement. The quality of patient-provider communication was worse for HIV-infected patients with unhealthy alcohol use but similar or better for illicit drug users compared with non-users. Interventions should be developed that encourage providers to actively engage patients with unhealthy alcohol use.
Figures
Similar articles
-
Differences in patient-provider communication for Hispanic compared to non-Hispanic white patients in HIV care.J Gen Intern Med. 2010 Jul;25(7):682-7. doi: 10.1007/s11606-010-1310-4. Epub 2010 Mar 18. J Gen Intern Med. 2010. PMID: 20238204 Free PMC article.
-
A Randomized Controlled Trial of IVR-Based Alcohol Brief Intervention to Promote Patient-Provider Communication in Primary Care.J Gen Intern Med. 2016 Sep;31(9):996-1003. doi: 10.1007/s11606-016-3692-4. Epub 2016 May 20. J Gen Intern Med. 2016. PMID: 27206539 Free PMC article. Clinical Trial.
-
Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients.Patient Educ Couns. 2015 Sep;98(9):1078-83. doi: 10.1016/j.pec.2015.05.011. Epub 2015 May 21. Patient Educ Couns. 2015. PMID: 26021185 Free PMC article.
-
Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.Cochrane Database Syst Rev. 2014 Dec 3;(12):CD009269. doi: 10.1002/14651858.CD009269.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Dec 05;12:CD009269. doi: 10.1002/14651858.CD009269.pub4. PMID: 25470303 Updated. Review.
-
Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.Cochrane Database Syst Rev. 2012 Nov 14;11:CD009269. doi: 10.1002/14651858.CD009269.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Dec 03;(12):CD009269. doi: 10.1002/14651858.CD009269.pub3. PMID: 23152270 Updated. Review.
Cited by
-
Patient perceptions of facilitators and barriers to reducing hazardous alcohol use among people living with HIV in East Africa.Subst Abuse Treat Prev Policy. 2023 Feb 3;18(1):8. doi: 10.1186/s13011-023-00520-7. Subst Abuse Treat Prev Policy. 2023. PMID: 36737735 Free PMC article.
-
HealthCall: A randomized trial assessing a smartphone enhancement of brief interventions to reduce heavy drinking in HIV care.J Subst Abuse Treat. 2022 Jul;138:108733. doi: 10.1016/j.jsat.2022.108733. Epub 2022 Jan 31. J Subst Abuse Treat. 2022. PMID: 35131124 Free PMC article. Clinical Trial.
-
Perceptions of Alcohol Risk Among HIV/Hepatitis C Coinfected Patients.J Addict Med. 2020 Jul/Aug;14(4):326-330. doi: 10.1097/ADM.0000000000000591. J Addict Med. 2020. PMID: 31651563 Free PMC article.
-
Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.Prev Med. 2019 Nov;128:105785. doi: 10.1016/j.ypmed.2019.105785. Epub 2019 Jul 27. Prev Med. 2019. PMID: 31362002 Free PMC article.
-
The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection.Drug Alcohol Depend. 2019 Aug 1;201:171-177. doi: 10.1016/j.drugalcdep.2019.03.024. Epub 2019 Jun 5. Drug Alcohol Depend. 2019. PMID: 31234013 Free PMC article. Clinical Trial.
References
-
- Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8. - PubMed
-
- Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103. - PubMed
-
- Mathews WC, McCutchan JA, Asch SM, et al. National estimates of HIV-related symptom prevalence from the HIV cost and services utilization study. Med Care. 2000;38(7):750–62. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AA016893/AA/NIAAA NIH HHS/United States
- R34 MH089279-02/MH/NIMH NIH HHS/United States
- R01 DA011602/DA/NIDA NIH HHS/United States
- U01 AI069918-05/AI/NIAID NIH HHS/United States
- K23 AA015313/AA/NIAAA NIH HHS/United States
- K23DA019809/DA/NIDA NIH HHS/United States
- K24 DA000432-10/DA/NIDA NIH HHS/United States
- K23 DA019809/DA/NIDA NIH HHS/United States
- R01 DA011602-13/DA/NIDA NIH HHS/United States
- R34 MH089279-01A1/MH/NIMH NIH HHS/United States
- R01 AA16893/AA/NIAAA NIH HHS/United States
- K24 DA000432/DA/NIDA NIH HHS/United States
- K08 HS013903/HS/AHRQ HHS/United States
- U01 DA036935/DA/NIDA NIH HHS/United States
- R34 MH089279/MH/NIMH NIH HHS/United States
- R01 DA11602/DA/NIDA NIH HHS/United States
- U01 AI069918/AI/NIAID NIH HHS/United States
- AHRQ 290-01-0012/PHS HHS/United States
- R01 AA016893-01A2/AA/NIAAA NIH HHS/United States
- K08 HS013903-05/HS/AHRQ HHS/United States
- K23AA015313/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
